| Title |
Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)
|
|---|---|
| Published in |
Journal of Cancer Research and Clinical Oncology, January 2006
|
| DOI | 10.1007/s00432-005-0074-4 |
| Pubmed ID | |
| Authors |
W. Pönisch, P. S. Mitrou, K. Merkle, M. Herold, M. Assmann, G. Wilhelm, K. Dachselt, P. Richter, V. Schirmer, A. Schulze, R. Šubert, B. Harksel, N. Grobe, E. Stelzer, M. Schulze, A. Bittrich, M. Freund, R. Pasold, Th. Friedrich, W. Helbig, D. Niederwieser |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Germany | 1 | 1% |
| Canada | 1 | 1% |
| Unknown | 94 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 23% |
| Other | 15 | 15% |
| Student > Ph. D. Student | 10 | 10% |
| Student > Master | 8 | 8% |
| Student > Doctoral Student | 6 | 6% |
| Other | 20 | 21% |
| Unknown | 16 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 51% |
| Nursing and Health Professions | 5 | 5% |
| Agricultural and Biological Sciences | 4 | 4% |
| Economics, Econometrics and Finance | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Other | 12 | 12% |
| Unknown | 19 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#5,690,774
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#266
of 2,632 outputs
Outputs of similar age
#20,264
of 158,541 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#2
of 7 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,541 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.